# Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation

> **NCT03062553** · NA · WITHDRAWN · sponsor: **University of British Columbia**

## Conditions studied

- Schizophrenia
- Psychosis
- Delusions

## Interventions

- **BEHAVIORAL:** Metacognitive Training (MCT)
- **BEHAVIORAL:** Sham/MCT
- **DEVICE:** transcranial alternating current stimulation (tACS)

## Key facts

- **NCT ID:** NCT03062553
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-02-01
- **Primary completion:** 2020-12-15
- **Final completion:** 2020-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Testing for this study remained in the pilot stages due to optimization of the tACS equipment. There are no clinical results to report.
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062553, "Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03062553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*